Loss of facial volume and soft-tissue support are common to types of facial aging. Restoration of a youthful appearance relies upon correction of this loss, and can be achieved in various capacities through use of biostimulatory or hyaluronic acids (HA) injectable fillers. Here, the authors discuss the versatility of calcium hydroxylapatite (CaHA) in volume replacement and the applications and facial regions for which CaHA, poly-L-lactic acid (PLLA), and HA fillers are best suited.
Soft-tissue fillers represent an increasingly important nonsurgical approach for achieving patient cosmetic goals. Beginning with the advent of bovine collagen by Knapp in 1977 , soft-tissue augmentation has emerged as an important nonsurgical mode of rejuvenation. 1 Evolution from initial approaches that were limited to filling in lines and wrinkles to a more holistic approach of addressing volume loss within discrete fat compartments of the face demands that repair of the aging face be considered in three dimensions. [2] [3] [4] [5] Loss of volume, whether from diminishing bony support or loss of soft tissue, must be corrected in order to restore a youthful appearance. Given the potential for revolumization to exert indirect effects on adjacent areas, patients require a global facial approach that includes both lending support and structure and addressing more superficial aesthetic needs. 6 Through clinical experience and consideration of the qualities of available agents, the authors propose areas suited to the use of calcium hydroxylapatite (Radiesse [CaHA] ; Merz North America, Inc., Raleigh, NC), poly-L-lactic acid (PLLA), and hyaluronic acid (HA) fillers, as well as strategies for their utilization in complementary treatment approaches. implant should not be visible or palpable. Following the procedure, the filler should be long-lasting yet biodegradable, promote a self-limiting fibroblastic response, be noncalcifying, remain in place, and be compatible with other cosmetic procedures, ideally those done in the same day.
Each FDA-approved filler has unique properties that make it best suited for specific areas of concern. Understanding these differentiating factors is important for making appropriate filler choices and achieving optimal results for facial shaping. As the field of injectable fillers continues to expand, practitioners are faced with deciding whether new treatments offer advances that are sufficient to warrant uptake in their practice. As it is universally difficult to apply FDA-recommended injection techniques, volumes, and amounts of material used to clinical practice, the development of handling experience, niche identification, and practices for optimum effect are left entirely in the hands of physicians. This increases financial risks to individual practices and presents a challenge for physicians who may find themselves overcoming multiple learning curves for essentially redundant treatments.
Fillers can be differentiated based on tolerability, capacity to provide lift or to address more superficial lines, and the anatomical regions in which they are safest and most effective. Patient-specific factors that may guide treatment approach include the desired timeline for results (ie, within a week rather than over the course of a month) or the ability of the patient to produce collagen, a capacity that diminishes with age. Though HA fillers are most frequently used, 7 the authors present here a range of applications for CaHA in revolumization of the aging face.
Facial Regions and the Global Facial Approach
With the recognition of the contribution of volume to overall youthful appearance came an appreciation of the interconnectedness of facial regions. Though the face may be divided into upper, mid, and lower regions, facial shaping requires a consideration of eleven regions (Figure 1 ). Though CaHA is only indicated for use in the face as treatment for nasolabial folds of facial lipoatrophy, 8 here the authors present several off-label uses for which CaHA is well suited. In addition to more detailed consideration of facial regions, the interdependent nature of these regions must be considered when planning a treatment approach. 6, 9 Correction in one region of the face may exert positive indirect effects on adjacent areas. For example, addressing volume depletion in the midface may minimize the need for treatment in the nasolabial folds. Finally, the ability of an agent to address asymmetry and permit fine tuning of shapes should be considered. This is a particular advantage of utilizing injectable fillers vs surgical approaches.
Injection Into the Supra-Periosteal Plane

Maximum Lift
When placed in the supraperiosteal plane, the force of the filler is focused entirely upon providing lift and volume to the overlying tissue. 10 The ability of CaHA to efficiently provide lift makes it an ideal treatment for areas that are notoriously hard to treat with HAs, such as the chin, temples, and malar area. In areas with nondistensible tissue, the lifting potential of the filler must be high, permitting the filler to behave most like a liquid implant so that it may provide sufficient projection. 11 Recent work describing the composite lifting achievable with CaHA highlights that it is especially well suited for injection in the supraperiosteal plane of the temple, zygomatic arch, anterior cheek, pyriform aperture, and prejowl sulcus where volume deficiencies should be addressed prior to more superficial complementary treatment with HA fillers. 6 
Compatibility With Other Treatments
CaHA is an especially versatile treatment, in part because of its compatibility with other treatments for repositioning and revolumization. Volumizing is a natural partner to initial repositioning and redraping through other methods, including Silhouette InstaLift sutures. The ideal approach addresses structural repositioning first, then issues of volume, followed by correction of more superficial issues. Adherence to this progression gives fillers a more natural look. Ideally, there should be at least a six-week period between repositioning with sutures and volumization with fillers. Because InstaLift is superficially placed, volumization within a different plane is an appealing way to maximize patient safety and aesthetic results.
Both CaHA and PLLA have been used for revolumization and treatment of lypoatrophy in HIV patients. 12, 13 CaHA may be used to complement fat grafting by layering over grafts to fine-tune shapes and address any asymmetries. CaHA may also be used following fat grafting for athletic patients with limited fat stores for harvest, or in a layered approach over PLLA.
As discussed in many of the case studies below, revolumization with CaHA may be followed by treatment of more superficial issues with HA. The different properties of CaHA and HA fillers, in conjunction with their placement in different planes, highlights their consideration as complementary rather than competing treatments. 14 
Safety
Injection into the supraperiosteal plane is advantageous; vasculature is avoided because the supraperiosteal plane is largely devoid of blood vessels. Even so, care should be taken to avoid the path of foramen and emanating arteries and nerves. Furthermore, the potential for shifting of vasculature into the supraperiosteal plane during surgery should be considered. Additionally, the high viscosity and G' of CaHA ensures that it remains within the compartment into which it is injected. 6 Finally, composite revolumization may eliminate the need for additional injections.
Though the argument may be made that the reversibility of HA fillers makes them inherently safer, the experience and training of the physician is of paramount importance in minimizing risks. As is the case for other agents, injected CaHA carries low risk when properly performed by an experienced clinician. To avoid filler complications, clinicians should ensure that the product is properly diluted, the patient is properly selected and prepared for the surgery, and that appropriate injection technique is used.
Upper Face Volume Loss
Forehead
This forehead is a region that has been historically ignored outside of toxins. HAs have limited efficacy in this area and there is a high risk of vascular compromise. Improving the convexity of the forehead, as well as treatments aimed at feminization, represent an unmet need in fillers. Injection of CaHA into the supraperiosteal plane in this area allows the physician to avoid vasculature, thereby minimizing risk, and provides correction sufficient to warrant the use of only light superficial HAs to remedy finer lines. When balancing risk against aesthetic outcomes, CaHA is both far safer and better able to produce the desired outcome. In contrast, use of HA fillers in this region presents a risk to the resident vasculature and generally delivers suboptimal results.
Temple
Though temple volume rarely represents a distinct primary concern of patients, its contribution to an overall youthful appearance should not be underestimated, especially in younger patients. The youthful temple is convex and continuous with the zygomatic arch such that the outline of the lateral orbital rim is not appreciable. 15 Temple revolumization lengthens and lifts the lateral brow and restores width to the face. Attention to this area ensures a complete approach to rejuvenation, as a perfectly balanced midface in the absence of attention to the upper face and temple may lead to a less natural aesthetic. CaHA is especially well suited to treat this area because of its lifting potential when placed in the supraperiosteal plane. 
Midface Volume Loss
An appreciation for the contribution of volume loss to facial aging informs optimal treatment strategy. Loss of volume and transverse width in the lateral midface can lead to an elongated or deflated appearance. Utilization of CaHA in the supraperiosteal plane in the cheek area replenishes volume and provides sufficient structural support and composite lifting and may eliminate the need for further treatment of nasolabial folds. Following initial treatment and provision of support, upper lip lines may be managed with a light HA or Botulinum Toxin Type A. In the clinical experience of the authors, 70% of patients are able to achieve aesthetic goals through correction of tissue loss, leaving only 30% in need of additional treatment above the muscle. Treatment options include PLLA or a heavy HA; however, among these choices, CaHA has the highest immediate lifting potential and is the only agent that provides both an immediate effect in conjunction with stimulation of collagen deposition in the extracellular matrix at the site of injection. 10, 16 Case studies of two patients from a recent publication show how initial treatment and provision of support with Radiesse gives rise to a fuller, more youthful appearance. 6 When addressing the cheeks, the authors recommend limiting placement of diluted CaHA inferior to the orbital rim. Because much of the tear trough is over bone, a deep injection in this region is well tolerated. In contrast, HAs placed within the soft tissue of this region present a significant risk of adverse events.
Nasolabial Folds
Creasing within the nasolabial folds requires a treatment that can provide lift, contour, and support to deeper structures. While less severe creasing may be handled with a bilayer treatment of a heavy HA, like VOLUMA or Restylane Lyft, injected into the subdermal plane and a more application of a lighter HA in the dermis, direct fill and cross-hatching with CaHA can lift the skin into a tighter conformation while providing support. CaHA is able to elevate elevation of deeper musculature and provide a platform for more superficial filling of fine lines. Especially in the case of deep creases, provision of this degree of support is difficult to obtain with even heavy HA fillers. For this reason, the authors consider CaHA a particularly valuable treatment for this anatomical area. 
Lips
Patient goals in this anatomical area often include reshaping, building volume to achieve aesthetic balance between the upper and lower lips, or addressing radial and/or vertical lip lines. In the lips, filler integration is of paramount importance. To address early marionette lines or superficial radial lip lines, direct fill and cross-hatching with HA fillers such as Belotero or Restylane Silk in the superficial dermis are often preferred strategies. Though Restylane silk has desirable flow characteristics, it has such strong hydrophilic properties that all patients experience swelling and require steroids upon treatment. Because Restylane provides superior definition in the white roll, the authors most commonly dilute Restylane rather than use Restylane Silk. When addressing vertical lip lines, an approach that involves restructuring the lip acutely and over time provides the desired outcome. Two lines of subcutaneous CaHA placed transversely across the white lip roll create a stiffer, flatter lip and replenishes collagen. Remaining vertical lines may be individually lined with a superficial HA such as Belotero. CaHA can be used much like a liquid implant to reconstruct a patient's collapsed pyriform and maxilla. Provision of deeper support in this region can permit restoration of lip contour and subsequent correction of the patient's finer lip lines. The authors agree that a treatment plan that is initiated in deeper planes and proceeds to address more superficial issues offers the best results, a consensus that lends further support to the 3-dimensional concept of rejuvenation.
None of the authors use PLLA around the lips or periorbital area, as many of the adverse events they have observed result from improper dilution or placement within concentric muscles.
Lower Face
Mandible
The ease with which CaHA may be injected over bony structures makes it an ideal candidate for addressing asymmetry or building volume along the mandible (Figure 3) . Over the mandible, an appropriately diluted bolus injection of CaHA may be spread through massage; spreading is limited only by lines of fusion.
Chin
In the chin area, the comparatively higher viscosity and G' of CaHA makes it the best-suited filler, as it supplies the maximum available lift. 
Acne Scars
In addition to its ability to restore volume in the supraperiosteal plane, judicious amounts of CaHA in the deep dermis are a well tolerated and durable treatment for acne scars ( Figure 4 ).
DISCUSSION
An emerging appreciation for the role of volume restoration in rejuvenation, coupled with the expanding number of treatment options, begs the question of which available fillers are best suited to achieve composite lifting and efficient revolumization in specific anatomical areas. Further, an understanding of how these treatments may be used in concert with other complementary approaches such as fat grafting or absorbable suspension sutures is central to obtaining optimal results for patients. The authors propose that CaHA is an ideal filler for providing structural support and volume within various areas of the face, particularly when injected into the supraperiosteal plane. This deep placement makes it an ideal partner for restructuring accomplished with absorbable sutures such as Silhouette InstaLift, fat grafting, or PLLA, and filling of more superficial lines with lighter HA fillers. CaHA is recognized as a valuable tool when the characteristics of a liquid implant are desired, especially in areas that are hard to treat with even heavy HAs such as the nasolabial folds and chin. Though this supplement provides a general overview of how CaHA may be used in different applications, treatment approaches should be individualized and crafted to suit the needs of each individual.
As is the case with all fillers, proper safety measures must be taken to avoid adverse events, and the experience of the injector is directly related to the outcome.
CONCLUSION
By considering CaHA as part of a layered approach to volume restoration, patient outcomes may be improved. By providing support, CaHA may serve as a scaffold for filling of fine lines or eliminate the need to treat adjacent areas altogether. Within each of the anatomical areas discussed, complementary treatment with other fillers or interventions, such as sutures, can lead to optimal results. The high G' of CaHA lends it to applications in which it may be considered a liquid implant, especially over hard-to-treat areas such as the chin and forehead.
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A B Figure 4 . A 37-year-old man (A) pre-and (B) 13-month posttreatment of acne scars with CaHA.
